Incap Oyj (LON:0ERY)
9.85
+0.14 (1.44%)
At close: Dec 23, 2025
Incap Oyj Revenue
Incap Oyj had revenue of 51.78M EUR in the quarter ending September 30, 2025, a decrease of -16.16%. This brings the company's revenue in the last twelve months to 219.68M, up 3.01% year-over-year. In the year 2024, Incap Oyj had annual revenue of 231.17M with 4.29% growth.
Revenue (ttm)
219.68M EUR
Revenue Growth
+3.01%
P/S Ratio
1.32
Revenue / Employee
244.09K EUR
Employees
900
Market Cap
253.34M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 231.17M | 9.51M | 4.29% |
| Dec 31, 2023 | 221.66M | -42.16M | -15.98% |
| Dec 31, 2022 | 263.82M | 94.01M | 55.36% |
| Dec 31, 2021 | 169.81M | 62.50M | 58.24% |
| Dec 31, 2020 | 107.31M | 35.31M | 49.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |